Salvatore U. Berlangieri

Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism

Christopher C. Rowe, Uwe Ackerman, William F. Browne et al. · The Lancet Neurology · 2008 · 664 citations

Positron Emission Tomography, Amyloid β, Neurodegenerative Diseases +10

Visual Assessment Versus Quantitative Assessment of 11C-PIB PET and 18F-FDG PET for Detection of Alzheimer's Disease

Siew Hiang Sally Ng, VL Villemagne, Salvatore U. Berlangieri et al. · Journal of Nuclear Medicine · 2007 · 257 citations · Full text

CLINICAL ROLE OF F-18 FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY FOR DETECTION AND MANAGEMENT OF RENAL CELL CARCINOMA

Shakher Ramdave, G. Thomas, Salvatore U. Berlangieri et al. · The Journal of Urology · 2001 · 201 citations

The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer1Presented at the 13th Asia Pacific Cancer Conference, Penang, Malaysia, November 17–20, 1996 and also presented at the Royal Australasian College of Radiologists 47th Annual General and Scientific Meeting, Perth, Western Australia, October 5–9th, 1996. Accepted for presentation at the American Radium Society 79th Annual Meeting, New York, N.Y., April 30–May 4, 1997.1

John D Kiffer, Salvatore U. Berlangieri, Andrew M. Scott et al. · Lung Cancer · 1998 · 189 citations

Oncologic Imaging, New York, Positron Emission Tomography +20

Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies.

Lawrence Cher, Carmel Murone, Nathan Lawrentschuk et al. · PubMed · 2006 · 178 citations